Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 3Ovarian Neoplasms 3Neoplasm Metastasis 3Fallopian Tube Neoplasms 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Peritoneal Neoplasms 1Neoplasms 1Melanoma 1Lymphoma, Follicular 1Lung Neoplasms 1Limited Stage Small Cell Lung Cancer 1Hepatic Encephalopathy 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

phenylacetic acid 1ammonul 1Sodium Benzoate 1Glucose 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Hepatic Encephalopathy × Glucose × Clear all
NCT00597909 2024-12-17

Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy

Amgen

Phase 2 Terminated
1 enrolled
Lymphoid

Hepatic Encephalopathy, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡